ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,433.76
0.63%
Dow Jones
39,512.84
0.32%
Gold vs US Dollar
2,360.48
0.00%
Brent Oil
82.585
0.00%
Bitcoin
60,936.28
0.23%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. BioPlus Acquisition Corporation (BIOSU)

  7. BioPlus Acquisition Corporation (BIOSU) News

BioPlus Acquisition (BIOSU)

BioPlus Acquisition Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BIOSU
DateTimeSourceHeadlineSymbolCompany
16/10/202321:15Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:BIOSUBioPlus Acquisition Corporation
04/10/202312:39Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:BIOSUBioPlus Acquisition Corporation
04/10/202312:32Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIOSUBioPlus Acquisition Corporation
04/10/202312:30GlobeNewswire Inc.BioPlus Acquisition Corp. Announces Termination of Business Combination Agreement with Avertix Medical, Inc. and its Intention to LiquidateNASDAQ:BIOSUBioPlus Acquisition Corporation
15/09/202321:00Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:BIOSUBioPlus Acquisition Corporation
16/08/202314:01Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:BIOSUBioPlus Acquisition Corporation
14/08/202321:11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BIOSUBioPlus Acquisition Corporation
17/07/202313:01Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:BIOSUBioPlus Acquisition Corporation
14/06/202311:09Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:BIOSUBioPlus Acquisition Corporation
14/06/202311:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOSUBioPlus Acquisition Corporation
30/05/202321:04Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:BIOSUBioPlus Acquisition Corporation
19/05/202321:50Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:BIOSUBioPlus Acquisition Corporation
19/05/202321:05Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:BIOSUBioPlus Acquisition Corporation
15/05/202321:29Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BIOSUBioPlus Acquisition Corporation
15/05/202311:38Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:BIOSUBioPlus Acquisition Corporation
12/05/202321:17Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:BIOSUBioPlus Acquisition Corporation
03/05/202313:47Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:BIOSUBioPlus Acquisition Corporation
03/05/202313:44Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOSUBioPlus Acquisition Corporation
27/04/202321:35Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:BIOSUBioPlus Acquisition Corporation
14/02/202320:39Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BIOSUBioPlus Acquisition Corporation
02/02/202315:10Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:BIOSUBioPlus Acquisition Corporation
03/11/202221:10Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BIOSUBioPlus Acquisition Corporation
11/10/202221:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOSUBioPlus Acquisition Corporation
10/08/202221:33Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BIOSUBioPlus Acquisition Corporation
12/05/202221:55Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BIOSUBioPlus Acquisition Corporation
11/03/202221:05Edgar (US Regulatory)Annual Report (10-k)NASDAQ:BIOSUBioPlus Acquisition Corporation
09/02/202219:14Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BIOSUBioPlus Acquisition Corporation
06/12/202113:00GlobeNewswire Inc.BioPlus Acquisition Corp. Announces Pricing of Upsized $200,000,000 Initial Public OfferingNASDAQ:BIOSUBioPlus Acquisition Corporation
03/12/202101:55GlobeNewswire Inc.BioPlus Acquisition Corp. Announces Pricing of Upsized $200,000,000 Initial Public OfferingNASDAQ:BIOSUBioPlus Acquisition Corporation
 Showing the most relevant articles for your search:NASDAQ:BIOSU

Your Recent History

TSXV
BUZD.P
High Mountain Capital
BTRX
KLAYUSDT
Klaytn
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved